Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2006-04-18
2006-04-18
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001690, C424S001110, C424S001650, C424S009200
Reexamination Certificate
active
07029653
ABSTRACT:
A method of the administration of drugs with binding affinity for plasma protein and drugs regulating the effective ingredient dose of drugs with binding affinity for plasma protein; and a preparation whereby the effective ingredient dose of drugs with binding affinity for plasma protein is regulated. The above administration method is characterized in that, in the administration of a first drug having binding affinity for plasma protein, a second drug having binding affinity for the same plasma protein is administered simultaneously with the first drug or before or after the administration of the first drug to thereby regulate the binding of the first drug to the plasma protein.
REFERENCES:
patent: 4642284 (1987-02-01), Cooper et al.
patent: 4976950 (1990-12-01), Simon et al.
patent: 5792444 (1998-08-01), Fischman et al.
patent: 5977163 (1999-11-01), Li et al.
patent: 196 48 629 (1998-05-01), None
patent: WO 98/39037 (1998-09-01), None
Somogyi et al (1981), British Journal of Clinical Pharmacology, vol. 12, pp. 51-60.
English Abstract, abstracting DE 196 48 629, May 14, 1998.
Mason et al, “In-Vitro Displacement of Indomethacin from Plasma Protein Binding By Ibuprofen Phenyl Butazone and Salicylate”, Univ. of Otago Medical School, vol. 52, No. 3, pp. 49-50 XP009000051 (1974).
Pritchard et al, “Plasma Protein Binding of Bepridil”, Journal of Clin. Pharm., vol. 25, No. 5, pp. 347-353 XP001083994 (1985).
Bertucci C et al, “The binding of 5-fluorouracil to native and modified human serum albumin: UV, CD and 1H and 19F NMR investigation”, Journal of Pharm. and Bio. Analysis, vol. 13, No. 9, XP002101869 (1995).
Kawai, K. et al., Compeittive displacement of 99mTc-MAG3 serum protein binding in in-vitro and in-vivo.:, Journal of Labelled Compounds and Radiopharmaceuticals, Jun. 1999, vol. 42, SUPPL. 1, pp. S584-S-586.
Bubeck, Berand et al., Pharmacokinetics of Technetium -99m-MAG3 in Humans.:, The Journal of Nuclear Medicine, 1990, vol. 31, No. 8, pp. 1285-1293.
Matsui, Mieko et al., “Application of fractional uptake method to 99mTc-ECD SPECT for quantification of brain perfusion using cardiac output index.”, Kobe Daigaku Igakubu Kiyo, 1998, vol. 58, No. 4, pp. 191-196, Abstract.
Ivarsen, Per Ramloev et al., “Displacement of bilirubin from adult and newborn serum albumiun by a drug and fatty acid.”, Dev. Pharmacol. Ther., 1989, vol. 12, No. 1, pp. 19-29.
Briand, C. et al., “Study of the interaction between human serum albumin and some cephalosporins.”, Mol. Pharmacol. 1982, vol. 21, No. 1, pp. 92-99.
Semmes, Robin L.O. et al., Nonlinear binding of valproic acid (VPA) and E-Δ2-valproic acid to rat plasma proteins.:, Pharm. Res. 1990, vol. 7, No. 5, pp. 461-467.
Lockwood, Graham F. et al., “Pharmacokinetics of ibuprofen in man-III: Plasma protein binding.”, J. Pharmacokinet. Biopharm. 1983, vol. 11, No. 5, pp. 469-482.
Abdel-Rahman M. et al., “Interaction between verapamil and vincristine binding to plasma proteins.”, International Journal of Clinical Pharmacology, Therapy, and Toxicology, 1992, vol. 30, No. 11, pp. 536-537.
Kawai Keiichi
Nishii Ryuichi
Takamura Norito
Jones Dameron L.
Nihon Medi+Physics Co., Ltd.
Sughrue & Mion, PLLC
LandOfFree
Method of the administration of drugs having binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of the administration of drugs having binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of the administration of drugs having binding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568986